Allergan Allows Amneal To Market Generic Namenda In 2020
Allergan PLC, formerly Actavis PLC, on Thursday announced it had settled with generic-drug maker Amneal Pharmaceuticals LLC over a generic version of Allergan's Alzheimer's treatment drug Namenda, allowing Amneal to begin...To view the full article, register now.
Already a subscriber? Click here to view full article